Celavie Biosciences CEO Sandy Solomon sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The California-based company is developing regenerative stem cell therapies to treat Parkinson’s disease and other central nervous system disorders.
Director Interviews
Christine Corrado
17:04 Tue 11 Feb 2020
viewCelavie Biosciences
Celavie Biosciences advancing its five year exploratory study in Parkinson's Disease
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Industry & services
US stocks close higher as coronavirus stimulus talks advance
20 hours, 13 minutes ago
Health
Gilead Sciences slams WHO after trial shows remdesivir not effective in...
5 days, 3 hours ago
